-
1
-
-
61949414868
-
Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy
-
Ingiliz P, Valantin MA, Duvivier C etal. Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy. Hepatology 2009; 49: 436-42.
-
(2009)
Hepatology
, vol.49
, pp. 436-442
-
-
Ingiliz, P.1
Valantin, M.A.2
Duvivier, C.3
-
2
-
-
41349094999
-
Performance of transient elastography for the staging of liver fibrosis: a meta-analysis
-
Friedrich-Rust M, Ong M, Martens S etal. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008; 134: 960-74.
-
(2008)
Gastroenterology
, vol.134
, pp. 960-974
-
-
Friedrich-Rust, M.1
Ong, M.2
Martens, S.3
-
3
-
-
61449097678
-
Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infection
-
Moreno S, Garcia-Samaniego J, Moreno A etal. Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infection. J. Viral Hepat. 2009; 16: 249-58.
-
(2009)
J. Viral Hepat.
, vol.16
, pp. 249-258
-
-
Moreno, S.1
Garcia-Samaniego, J.2
Moreno, A.3
-
4
-
-
34848908660
-
The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection
-
Vergara S, Macias J, Rivero A etal. The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection. Clin. Infect. Dis. 2007; 45: 969-74.
-
(2007)
Clin. Infect. Dis.
, vol.45
, pp. 969-974
-
-
Vergara, S.1
Macias, J.2
Rivero, A.3
-
5
-
-
67650450829
-
Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy
-
Chang PE, Miquel R, Blanco JL etal. Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy. Am. J. Gastroenterol. 2009; 104: 1707-14.
-
(2009)
Am. J. Gastroenterol.
, vol.104
, pp. 1707-1714
-
-
Chang, P.E.1
Miquel, R.2
Blanco, J.L.3
-
6
-
-
42149138423
-
Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome
-
Maida I, Garcia-Gasco P, Sotgiu G etal. Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome. Antivir. Ther. 2008; 13: 103-7.
-
(2008)
Antivir. Ther.
, vol.13
, pp. 103-107
-
-
Maida, I.1
Garcia-Gasco, P.2
Sotgiu, G.3
-
7
-
-
74049108154
-
Cryptogenic pseudocirrhosis: a new clinical syndrome of noncirrhotic portal hypertension (unassociated with advanced fibrosis) that can be detected by transient elastography in patients with HIV
-
Panos G, Farouk L, Stebbing J etal. Cryptogenic pseudocirrhosis: a new clinical syndrome of noncirrhotic portal hypertension (unassociated with advanced fibrosis) that can be detected by transient elastography in patients with HIV. J. Acquir. Immune Defic. Syndr. 2009; 52: 525-7.
-
(2009)
J. Acquir. Immune Defic. Syndr.
, vol.52
, pp. 525-527
-
-
Panos, G.1
Farouk, L.2
Stebbing, J.3
-
8
-
-
77951880387
-
Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings
-
Vispo E, Moreno A, Maida I etal. Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings. AIDS 2010; 24: 1171-6.
-
(2010)
AIDS
, vol.24
, pp. 1171-1176
-
-
Vispo, E.1
Moreno, A.2
Maida, I.3
-
9
-
-
34247578033
-
Nodular regenerative hyperplasia of liver as a consequence of ART
-
Arey B, Markow M, Ravi J, Prevette E, Batts K, Nadir A. Nodular regenerative hyperplasia of liver as a consequence of ART. AIDS 2007; 21: 1066-8.
-
(2007)
AIDS
, vol.21
, pp. 1066-1068
-
-
Arey, B.1
Markow, M.2
Ravi, J.3
Prevette, E.4
Batts, K.5
Nadir, A.6
-
10
-
-
77951909387
-
Anticoagulant therapy for nodular regenerative hyperplasia in a HIV-infected patient
-
Bihl F, Janssens F, Boehlen F, Rubbia-Brandt L, Hadengue A, Spahr L. Anticoagulant therapy for nodular regenerative hyperplasia in a HIV-infected patient. BMC Gastroenterol. 2010; 10: 6.
-
(2010)
BMC Gastroenterol.
, vol.10
, pp. 6
-
-
Bihl, F.1
Janssens, F.2
Boehlen, F.3
Rubbia-Brandt, L.4
Hadengue, A.5
Spahr, L.6
-
11
-
-
67650699241
-
Cryptogenic liver disease in HIV-seropositive men
-
Dinh MH, Stosor V, Rao SM, Miller FH, Green RM. Cryptogenic liver disease in HIV-seropositive men. HIV Med. 2009; 10: 447-53.
-
(2009)
HIV Med.
, vol.10
, pp. 447-453
-
-
Dinh, M.H.1
Stosor, V.2
Rao, S.M.3
Miller, F.H.4
Green, R.M.5
-
12
-
-
77953394322
-
Noncirrhotic portal hypertension: another cause of liver disease in HIV patients
-
Mendizabal M, Craviotto S, Chen T, Silva MO, Reddy KR. Noncirrhotic portal hypertension: another cause of liver disease in HIV patients. Ann. Hepatol. 2009; 8: 390-5.
-
(2009)
Ann. Hepatol.
, vol.8
, pp. 390-395
-
-
Mendizabal, M.1
Craviotto, S.2
Chen, T.3
Silva, M.O.4
Reddy, K.R.5
-
13
-
-
52949136988
-
Noncirrhotic portal hypertension in patients with human immunodeficiency virus-1 infection
-
Saifee S, Joelson D, Braude J etal. Noncirrhotic portal hypertension in patients with human immunodeficiency virus-1 infection. Clin. Gastroenterol. Hepatol. 2008; 6: 1167-9.
-
(2008)
Clin. Gastroenterol. Hepatol.
, vol.6
, pp. 1167-1169
-
-
Saifee, S.1
Joelson, D.2
Braude, J.3
-
14
-
-
62649104798
-
Upper gastrointestinal bleeding may unmask didanosine-associated portal hepatopathy in HIV/HCV co-infected patients
-
Vispo E, Maida I, Barreiro P, Moreno V, Soriano V. Upper gastrointestinal bleeding may unmask didanosine-associated portal hepatopathy in HIV/HCV co-infected patients. HIV Clin. Trials 2008; 9: 440-4.
-
(2008)
HIV Clin. Trials
, vol.9
, pp. 440-444
-
-
Vispo, E.1
Maida, I.2
Barreiro, P.3
Moreno, V.4
Soriano, V.5
-
15
-
-
49649101086
-
A new indication for liver transplantation: nodular regenerative hyperplasia in human immunodeficiency virus-infected patients
-
Tateo M, Sebagh M, Bralet M etal. A new indication for liver transplantation: nodular regenerative hyperplasia in human immunodeficiency virus-infected patients. Liver Transpl. 2008; 14: 1194-8.
-
(2008)
Liver Transpl.
, vol.14
, pp. 1194-1198
-
-
Tateo, M.1
Sebagh, M.2
Bralet, M.3
-
16
-
-
0014495162
-
Obliterative portal venopathy of the liver. Associated with so-called idiopathic portal hypertension or tropical splenomegaly
-
Nayak N, Ramalingaswami V. Obliterative portal venopathy of the liver. Associated with so-called idiopathic portal hypertension or tropical splenomegaly. Arch. Pathol. 1969; 87: 359-69.
-
(1969)
Arch. Pathol.
, vol.87
, pp. 359-369
-
-
Nayak, N.1
Ramalingaswami, V.2
-
17
-
-
84987574189
-
Obliterative portal venopathy: a comparison study of 184 cases of extrahepatic portal obstruction and 469 cases of idiopathic portal hypertension
-
Kameda H, Yamazaki K, Imai F, Sugiura M, Nakashima T, Okuda K. Obliterative portal venopathy: a comparison study of 184 cases of extrahepatic portal obstruction and 469 cases of idiopathic portal hypertension. J. Gastroenterol. Hepatol. 1986; 1: 139-49.
-
(1986)
J. Gastroenterol. Hepatol.
, vol.1
, pp. 139-149
-
-
Kameda, H.1
Yamazaki, K.2
Imai, F.3
Sugiura, M.4
Nakashima, T.5
Okuda, K.6
-
18
-
-
35448944283
-
Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV
-
Schiano T, Kotler D, Ferran E, Fiel M. Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV. Am. J. Gastroenterol. 2007; 102: 2536-40.
-
(2007)
Am. J. Gastroenterol.
, vol.102
, pp. 2536-2540
-
-
Schiano, T.1
Kotler, D.2
Ferran, E.3
Fiel, M.4
-
19
-
-
33745878829
-
Nodular regenerative hyperplasia: not all nodules are created equal
-
Reshamwala P, Kleiner D, Heller T. Nodular regenerative hyperplasia: not all nodules are created equal. Hepatology 2006; 44: 7-14.
-
(2006)
Hepatology
, vol.44
, pp. 7-14
-
-
Reshamwala, P.1
Kleiner, D.2
Heller, T.3
-
20
-
-
34250890211
-
Response to Mallet, "Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients."
-
Garvey L, Thomson E, Lloyd J, Cooke G, Goldin R, Main J. Response to Mallet etal., "Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients." AIDS 2007; 21: 1494-5.
-
(2007)
AIDS
, vol.21
, pp. 1494-1495
-
-
Garvey, L.1
Thomson, E.2
Lloyd, J.3
Cooke, G.4
Goldin, R.5
Main, J.6
-
21
-
-
33845945366
-
Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients
-
Mallet VP, Blanchard V, Verkarre A etal. Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients. AIDS 2007; 21: 187-92.
-
(2007)
AIDS
, vol.21
, pp. 187-192
-
-
Mallet, V.P.1
Blanchard, V.2
Verkarre, A.3
-
22
-
-
79951681146
-
The role of nucleoside and nucleotide analogues in nodular regenrative hyperplasia in HIV-infected patients: a case control study
-
Cotte L, Bénet T, Billioud C etal. The role of nucleoside and nucleotide analogues in nodular regenrative hyperplasia in HIV-infected patients: a case control study. J. Hepatol. 2011; 54: 589-496.
-
(2011)
J. Hepatol.
, vol.54
, pp. 589-496
-
-
Cotte, L.1
Bénet, T.2
Billioud, C.3
-
23
-
-
67651086987
-
Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study
-
Kovari H, Ledergerber B, Peter U etal. Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study. Clin. Infect. Dis. 2009; 49: 626-35.
-
(2009)
Clin. Infect. Dis.
, vol.49
, pp. 626-635
-
-
Kovari, H.1
Ledergerber, B.2
Peter, U.3
-
24
-
-
33845692257
-
Liver fibrosis in HIV-infected patients with chronic hepatitis B extensively exposed to antiretroviral therapy with anti-HBV activity
-
Maida I, Soriano V, Castellares C etal. Liver fibrosis in HIV-infected patients with chronic hepatitis B extensively exposed to antiretroviral therapy with anti-HBV activity. HIV Clin. Trials 2006; 7: 246-50.
-
(2006)
HIV Clin. Trials
, vol.7
, pp. 246-250
-
-
Maida, I.1
Soriano, V.2
Castellares, C.3
-
25
-
-
78149429491
-
Noncirrhotic portal hypertension in HIV-infected patients: a case control evaluation and review of the literature
-
Cesari M, Schiavini M, Marchetti G etal. Noncirrhotic portal hypertension in HIV-infected patients: a case control evaluation and review of the literature. AIDS Patient Care STDS 2010; 24(11): 697-703.
-
(2010)
AIDS Patient Care STDS
, vol.24
, Issue.11
, pp. 697-703
-
-
Cesari, M.1
Schiavini, M.2
Marchetti, G.3
-
26
-
-
68649114845
-
Acquired protein S deficiency leads to obliterative portal venopathy and to compensatory nodular regenerative hyperplasia in HIV-infected patients
-
Mallet V, Varthaman A, Lasne D etal. Acquired protein S deficiency leads to obliterative portal venopathy and to compensatory nodular regenerative hyperplasia in HIV-infected patients. AIDS 2009; 23: 1511-18.
-
(2009)
AIDS
, vol.23
, pp. 1511-1518
-
-
Mallet, V.1
Varthaman, A.2
Lasne, D.3
-
27
-
-
79951674881
-
Obliterative portal venopathy: portal hypertension is not always present at diagnosis
-
Cazals-Hatem D, Hillaire S, Rudler M etal. Obliterative portal venopathy: portal hypertension is not always present at diagnosis. J. Hepatol. 2011; 54: 455-61.
-
(2011)
J. Hepatol.
, vol.54
, pp. 455-461
-
-
Cazals-Hatem, D.1
Hillaire, S.2
Rudler, M.3
-
28
-
-
0032801286
-
Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy
-
Li D, Friedman SL. Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy. J. Gastroenterol. Hepatol. 1999; 14: 618-33.
-
(1999)
J. Gastroenterol. Hepatol.
, vol.14
, pp. 618-633
-
-
Li, D.1
Friedman, S.L.2
-
29
-
-
77955704597
-
Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: implications for the pathogenesis of HIV/hepatitis C virus-induced liver fibrosis
-
Tuyama A, Hong F, Saiman Y etal. Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: implications for the pathogenesis of HIV/hepatitis C virus-induced liver fibrosis. Hepatology 2010; 52: 612-22.
-
(2010)
Hepatology
, vol.52
, pp. 612-622
-
-
Tuyama, A.1
Hong, F.2
Saiman, Y.3
-
30
-
-
70349577112
-
Elevated liver enzymes in HIV monoinfected patients on HIV therapy: what are the implications?
-
Ingiliz P, Benhamou Y. Elevated liver enzymes in HIV monoinfected patients on HIV therapy: what are the implications? J. HIV Ther. 2009; 14: 3-7.
-
(2009)
J. HIV Ther.
, vol.14
, pp. 3-7
-
-
Ingiliz, P.1
Benhamou, Y.2
-
31
-
-
61949414868
-
Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy.
-
Ingiliz P, Valantin MA, Duvivier C etal. Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy. Hepatology 2009; 49(2): 436-42.
-
(2009)
Hepatology
, vol.49
, Issue.2
, pp. 436-442
-
-
Ingiliz, P.1
Valantin, M.A.2
Duvivier, C.3
-
33
-
-
84865363769
-
British HIV Association guidelines for anti-retroviral treatment of HIV seropositive individuals
-
BHIVA Guidelines Co-ordinating Committee
-
BHIVA Guidelines Co-ordinating Committee. British HIV Association guidelines for anti-retroviral treatment of HIV seropositive individuals. Lancet 1997; 349: 108S92.
-
(1997)
Lancet
, vol.349
-
-
-
35
-
-
0024349612
-
In vivo activity against HIV and favorable toxicity profile of 2′,3′-dideoxyinosine
-
Yarchoan R, Mitsuya H, Thomas RV etal. In vivo activity against HIV and favorable toxicity profile of 2′, 3′-dideoxyinosine. Science 1989; 245: 412-15.
-
(1989)
Science
, vol.245
, pp. 412-415
-
-
Yarchoan, R.1
Mitsuya, H.2
Thomas, R.V.3
-
36
-
-
0035810637
-
Fatal portal hypertension, liver failure, and mitochondrial dysfunction after HIV-1 nucleoside analogue-induced hepatitis and lactic acidaemia
-
Carr A, Morey A, Mallon P, Williams D, Thorburn DR. Fatal portal hypertension, liver failure, and mitochondrial dysfunction after HIV-1 nucleoside analogue-induced hepatitis and lactic acidaemia. Lancet 2001; 357: 1412-14.
-
(2001)
Lancet
, vol.357
, pp. 1412-1414
-
-
Carr, A.1
Morey, A.2
Mallon, P.3
Williams, D.4
Thorburn, D.R.5
-
37
-
-
79951726145
-
The development of hepatoportal sclerosis and portal hypertension due to didanosine use in HIV
-
Schiano TD, Uriel A, Dieterich DT, Fiel MI. The development of hepatoportal sclerosis and portal hypertension due to didanosine use in HIV. Virchows Arch. 2011; 458: 231-5.
-
(2011)
Virchows Arch.
, vol.458
, pp. 231-235
-
-
Schiano, T.D.1
Uriel, A.2
Dieterich, D.T.3
Fiel, M.I.4
-
38
-
-
77956624153
-
Clinical syndromes and consequences of antiretroviral-related hepatotoxicity
-
Nunez M. Clinical syndromes and consequences of antiretroviral-related hepatotoxicity. Hepatology 2010; 52: 1143-55.
-
(2010)
Hepatology
, vol.52
, pp. 1143-1155
-
-
Nunez, M.1
-
39
-
-
78349313190
-
Noncirrhotic human nonalcoholic fatty liver disease induces portal hypertension in relation to the histological degree of steatosis
-
Francque S, Verrijken A, Mertens I etal. Noncirrhotic human nonalcoholic fatty liver disease induces portal hypertension in relation to the histological degree of steatosis. Eur. J. Gastroentrol. Hepatol. 2010; 22: 1449-57.
-
(2010)
Eur. J. Gastroentrol. Hepatol.
, vol.22
, pp. 1449-1457
-
-
Francque, S.1
Verrijken, A.2
Mertens, I.3
|